R/R AML

Clinical trials for R/R AML explained in plain language.

Never miss a new study

Get alerted when new R/R AML trials appear

Sign up with your email to follow new studies for R/R AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New antibody GEN3018 enters first human tests for tough blood cancers

Disease control Recruiting now

This early-stage trial is testing a new antibody drug called GEN3018 in people whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) has come back or stopped responding to treatment. The main goal is to check safety and find the right dose. Up to 78 parti…

Matched conditions: R/R AML

Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control

Last updated Jun 27, 2026 13:01 UTC

R/R AML

Get alerted when new R/R AML trials appear

New antibody GEN3018 enters first human tests for tough blood cancers